0001213900-21-010856.txt : 20210222 0001213900-21-010856.hdr.sgml : 20210222 20210222162755 ACCESSION NUMBER: 0001213900-21-010856 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210222 DATE AS OF CHANGE: 20210222 EFFECTIVENESS DATE: 20210222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silo Pharma, Inc. CENTRAL INDEX KEY: 0001514183 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] IRS NUMBER: 462137136 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390105 FILM NUMBER: 21660711 BUSINESS ADDRESS: STREET 1: 560 SYLVAN AVE STREET 2: SUITE 3160 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: (718) 400-9031 MAIL ADDRESS: STREET 1: 560 SYLVAN AVE STREET 2: SUITE 3160 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 FORMER COMPANY: FORMER CONFORMED NAME: Uppercut Brands, Inc. DATE OF NAME CHANGE: 20190808 FORMER COMPANY: FORMER CONFORMED NAME: Point Capital, Inc. DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: Gold Swap Inc DATE OF NAME CHANGE: 20110301 D 1 primary_doc.xml X0708 D LIVE 0001514183 Silo Pharma, Inc. 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 718-400-9031 DELAWARE None Uppercut Brands, Inc. Point Capital, Inc. Gold Swap Inc Corporation true Eric Weisblum 560 Sylvan Avenue Suite 3160 Englewood Cliffs NJ NEW JERSEY 07632 Executive Officer Director Chief Executive Officer, Chief Financial Officer and President Wayne D. Linsley 560 Sylvan Avenue Suite 3160 Englewood Cliffs NJ NEW JERSEY 07632 Director Kevin Munoz 560 Sylvan Avenue Suite 3160 Englewood Cliffs NJ NEW JERSEY 07632 Director Pharmaceuticals Decline to Disclose 06b false 2021-02-12 false true true true false 0 Bradley Woods & Co. Ltd. 13660 None None 805 THIRD AVENUE., 18TH FLOOR NEW YORK NY NEW YORK 10022 CT CONNECTICUT NY NEW YORK PA PENNSYLVANIA false Katalyst Securities LLC 112494 None None 630 THIRD AVENUE NEW YORK NY NEW YORK 10017 AZ ARIZONA CA CALIFORNIA CT CONNECTICUT FL FLORIDA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK SD SOUTH DAKOTA TN TENNESSEE TX TEXAS false 4276000 4276000 0 false 47 404400 0 Excludes (i) fees paid to the placement agent's legal counsel and (ii) warrants to purchase up to an aggregate of 2,850,664 shares of common stock issued to the co-placement agents. 0 false Silo Pharma, Inc. /s/ Eric Weisblum Eric Weisblum Chief Executive Officer 2021-02-22